Your browser doesn't support javascript.
loading
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Zimmermann, Heiner; Koenecke, Christian; Dreyling, Martin H; Pott, Christiane; Dührsen, Ulrich; Hahn, Dennis; Meidenbauer, Norbert; Hauser, Ingeborg A; Rummel, Mathias J; Wolf, Dominik; Heuser, Michael; Schmidt, Christian; Schlattmann, Peter; Ritgen, Matthias; Siebert, Reiner; Oschlies, Ilske; Anagnostopoulos, Ioannis; Trappe, Ralf U.
Afiliación
  • Zimmermann H; Department of Hematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus, Bremen, Germany.
  • Koenecke C; Pius-Hospital, University Medicine Oldenburg, Department of Hematology and Oncology, Oldenburg, Germany.
  • Dreyling MH; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Pott C; Department of Internal Medicine III, LMU Klinikum, Munic, Germany.
  • Dührsen U; Department of Internal Medicine II: Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Hahn D; Department of Hematology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.
  • Meidenbauer N; Department of Hematology, Oncology and Palliative Care, Katharinenhospital, Stuttgart, Germany.
  • Hauser IA; Department of Medicine 5, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Rummel MJ; Department of Nephrology, UKF, Goethe University Frankfurt, Frankfurt/Main, Germany.
  • Wolf D; Department of Hematology, Clinic for Haematology and Medical Oncology, Justus Liebig University Hospital, Gießen, Germany.
  • Heuser M; Internal Medicine 3, Hematology, Oncology, Immunooncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
  • Schmidt C; University Clinic V, Department of Hematology and Oncology, and Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Schlattmann P; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Ritgen M; Department of Internal Medicine III, LMU Klinikum, Munic, Germany.
  • Siebert R; Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany.
  • Oschlies I; Department of Internal Medicine II: Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Anagnostopoulos I; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Trappe RU; Department of Hematopathology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Leukemia ; 36(10): 2468-2478, 2022 10.
Article en En | MEDLINE | ID: mdl-35974101
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Órganos / Trastornos Linfoproliferativos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Órganos / Trastornos Linfoproliferativos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido